WallStreetZenWallStreetZen

NASDAQ: PASG
Passage Bio Inc Stock Ownership - Who owns Passage Bio?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Passage Bio Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Lynx1 Capital Management LP10% Owner2025-09-1511,900$6.99
$83.17kBuy
Lynx1 Capital Management LP10% Owner2025-09-1219,783$6.99
$138.30kBuy
Lynx1 Capital Management LP10% Owner2025-09-11325$6.96
$2.26kBuy
Lynx1 Capital Management LP10% Owner2025-07-2466,423$5.71
$379.47kBuy
Lynx1 Capital Management LP10% Owner2025-07-2349,302$5.74
$283.04kBuy
Lynx1 Capital Management LP10% Owner2025-07-2213,123$5.44
$71.34kBuy
Orbimed Advisors LLC10% Owner2025-06-26213,257$0.33
$70.37kSell
Orbimed Advisors LLC10% Owner2025-06-25138,800$0.33
$45.80kSell
Orbimed Advisors LLC10% Owner2025-06-24231,600$0.35
$81.06kSell
Orbimed Advisors LLC10% Owner2025-04-2468,195$0.32
$21.82kSell

1 of 4

PASG insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PASG insiders and whales buy or sell their stock.

PASG Shareholders

What type of owners hold Passage Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC377.94%12,013,666$84.10MInsider
Lynx1 Capital Management LP291.22%9,256,953$64.80MInstitution
Vestal Point Capital LP191.90%6,100,000$42.70MInstitution
Orbimed Advisors LLC190.50%6,055,300$42.39MInstitution
Frazier Life Sciences IX LP157.59%5,009,219$35.06MInsider
Patrick J. Heron157.59%5,009,219$35.06MInsider
Versant Venture Capital VI LP156.03%4,959,769$34.72MInsider
Thomas Woiwode156.03%4,959,769$34.72MInsider
Liam Ratcliffe82.41%2,619,430$18.34MInsider
New Leaf Venture Partners LLC78.58%2,497,922$17.49MInstitution

1 of 3

PASG vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PASG48.56%51.44%Net SellingNet Selling
QTTB30.40%69.60%Net BuyingNet Selling
PMN16.36%46.67%Net Buying
FBLG12.20%14.47%Net Buying
NEUP2.62%97.38%
View Top Biotech Stocks

Passage Bio Stock Ownership FAQ

Who owns Passage Bio?

Passage Bio (NASDAQ: PASG) is owned by 1,102.86% institutional shareholders, 1,168.06% Passage Bio insiders, and 0.00% retail investors. Orbimed Advisors LLC is the largest individual Passage Bio shareholder, owning 12.01M shares representing 377.94% of the company. Orbimed Advisors LLC's Passage Bio shares are currently valued at $83.49M.

If you're new to stock investing, here's how to buy Passage Bio stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.